08:14 AM EST, 12/09/2024 (MT Newswires) -- Apollo Global Management's ( APO ) Novolex has agreed to buy Pactiv Evergreen ( PTVE ) for $18 per share in an all-cash deal valued at $6.70 billion, the companies said Monday.

Following deal closure expected in mid-2025, Pactiv Evergreen ( PTVE ) shares will no longer be listed on the Nasdaq and the combined company will be led by Novolex CEO and Chairman Stan Bikulege, the companies said.